ARLINGTON, Va.

阿灵顿，弗吉尼亚州

,

，

July 10, 2025

2025年7月10日

/PRNewswire/ -- Kalorama Information, a leading healthcare market intelligence firm, has published a comprehensive new report,

/PRNewswire/ -- Kalorama Information，一家领先的医疗保健市场情报公司，发布了一份全面的新报告，

Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

全球免疫测定市场：趋势、技术与增长机遇，2025年

. The report provides an in-depth global analysis of the immunoassay diagnostics segment, a

该报告提供了免疫分析诊断领域的深入全球分析，

$37.4 billion

374亿美元

market that spans centralized laboratories, point-of-care (POC) settings, and self-testing applications.

覆盖中心实验室、床旁（POC）设置和自测应用的市场。

Continue Reading

继续阅读

View PDF

查看PDF

Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

全球免疫测定市场：趋势、技术与增长机遇，2025年

The study offers forecasts through 2029 and identifies growth hotspots in autoimmune diagnostics, personalized medicine, and infectious disease testing—critical segments in both developed and emerging markets. Key findings also spotlight Roche's leadership, commanding 20.3% of the market, and

该研究提供了截至2029年的预测，并确定了自身免疫诊断、个性化医疗和传染病检测领域的增长热点——这些是发达市场和新兴市场的关键细分领域。主要发现还突显了罗氏的领导地位，其占据了20.3%的市场份额，并且

China's

中国的

ascent as the fastest-growing country in the

作为增长最快的国家的崛起

Asia Pacific

亚太地区

region, now comprising 37% of the APAC's immunoassay revenues.

区域，目前占亚太地区免疫测定收入的37%。

'While immunoassays are well-established in clinical diagnostics, their evolution continues to accelerate,' said

“虽然免疫分析法在临床诊断中已经很成熟，但其发展仍在不断加速，”

Daniel Granderson

丹尼尔·格兰德森

, Senior Editor at Kalorama Information. 'Miniaturization, multiplexing, and AI-assisted interpretation are redefining how and where these assays are used—from intensive care units to home settings.'

Kalorama Information的高级编辑表示：“微型化、多重化和人工智能辅助解读正在重新定义这些检测方法的使用方式和地点——从重症监护室到家庭环境。”

Market Highlights

市场亮点

Autoimmune immunoassay market expected to exceed

自身免疫免疫分析市场预计将超过

$1 billion

10亿美元

by 2029, fueled by increased clinical testing and diagnostic sophistication.

到2029年，随着临床检测的增加和诊断技术的复杂化，这一数字将进一步增长。

Genetic testing immunoassay segment projected to grow at a 9.1% CAGR from 2024 to 2029, driven by precision medicine and demand for personalized diagnostics.

遗传学检测免疫分析领域预计从2024年到2029年将以9.1%的年复合增长率增长，增长动力来自精准医疗和对个性化诊断的需求。

Infectious diseases remain the largest segment of lab-based immunoassays, with HIV, hepatitis B and C, and respiratory testing leading global test volumes.

传染病仍然是基于实验室的免疫测定的最大领域，其中艾滋病、乙型和丙型肝炎以及呼吸系统检测引领全球检测量。

Roche, Abbott, and Siemens Healthineers dominate the market, though over 100 other companies, including regional and niche players, are competing with specialized offerings in allergy, fertility, oncology, and more.

罗氏、雅培和西门子医疗主导市场，尽管还有100多家其他公司，包括区域性和利基企业，正在过敏、生育、肿瘤学等领域以专业化产品展开竞争。

Strategic Value for Industry Leaders

行业领导者的战略价值

Kalorama's report is tailored to meet the intelligence needs of stakeholders across the diagnostics landscape:

卡尔奥拉马的报告旨在满足诊断领域各利益相关者的情报需求：

Product & Portfolio Managers can prioritize segments with high-growth potential and sunset underperforming legacy platforms.

产品和投资组合经理可以优先考虑高增长潜力的细分市场，并逐步淘汰表现不佳的传统平台。

R&D Directors and Clinical Scientists gain insights into biomarker innovation and assay design trends.

研发总监和临床科学家深入了解生物标志物创新和检测设计趋势。

Investors and M&A Analysts can benchmark revenue leaders, discover white-space opportunities, and validate targets for acquisition or partnership.

投资者和并购分析师可以对标收入领先者，发现空白市场机会，并验证收购或合作目标。

Healthcare and MedTech Executives gain essential foresight to shape commercialization, expansion, and competitive positioning strategies.

医疗保健和医疗技术高管获得了制定商业化、扩张和竞争定位战略的关键前瞻性视野。

Why It Matters Now

为什么现在重要

Immunoassays remain foundational to diagnostic medicine—but are no longer confined to the lab. As the world contends with aging populations, rising chronic disease rates, and increasing demand for

免疫测定法仍然是诊断医学的基础——但不再局限于实验室。随着世界面临人口老龄化、慢性病发病率上升以及对医疗需求的不断增加，

decentralized

去中心化

care, immunoassay technologies are being reengineered to meet the moment. From at-home hormone testing kits to genetic profiling tools in oncology, this evolving market is set to shape the next decade of clinical diagnostics and health technology innovation.

护理、免疫测定技术正在重新设计以应对当前的需求。从家庭激素检测套件到肿瘤学中的基因分析工具，这一不断发展的市场将塑造未来十年的临床诊断和健康技术创新。

About the Report

关于报告

Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

全球免疫测定市场：趋势、技术与增长机会，2025年

is based on detailed analysis of company financials, product pipelines, primary interviews with over 30 industry experts, and a robust methodology combining secondary research, proprietary data, and verified forecasts. Market sizing reflects manufacturer-level revenue across more than 10 disease categories and key global regions..

基于对公司财务、产品线的详细分析，与30多位行业专家的初步访谈，以及结合二手研究、专有数据和经过验证的预测的强大方法论。市场规模反映了在10多个疾病类别和关键全球区域的制造商层面收入。

Purchase the report on Kalorama's website at

在Kalorama的网站上购买报告

https://www.scienceandmedicinegroup.com/product/global-immunoassay-market-trends-technologies-and-growth-opportunities-2025/

https://www.scienceandmedicinegroup.com/product/global-immunoassay-market-trends-technologies-and-growth-opportunities-2025/

.

。

Media Contacts

媒体联系人

To purchase the full report or schedule a custom consultation, contact:

要购买完整报告或安排定制咨询，请联系：

Sheri Davie

雪莉·戴维斯

Sales Director, Kalorama Information

销售总监，Kalorama信息

sheri.davie@scienceandmedicinegroup.com

雪莉·戴维 <sheri.davie@scienceandmedicinegroup.com>

For media inquiries:

媒体咨询：

Richa Singh

里查·辛格

Vice President, Strategic & Insights Sales

副总裁，战略与洞察销售

richa.singh@scienceandmedicinegroup.com

里查·辛格@科学与医学集团.com

About Kalorama Information

关于Kalorama信息

Kalorama Information, part of Science and Medicine Group Inc., has been a trusted source of market intelligence in healthcare diagnostics for over 25 years. With a focus on in vitro diagnostics, biotechnology, medical devices, and pharmaceuticals, Kalorama is recognized for delivering evidence-based insights that inform global business strategies.

Science and Medicine Group Inc. 旗下的 Kalorama Information 在医疗诊断领域的市场情报方面已经拥有超过 25 年的可信赖经验。Kalorama 专注于体外诊断、生物技术、医疗器械和制药领域，以提供基于证据的洞察而闻名，这些洞察为全球商业战略提供了重要参考。

Kalorama also collaborates with other SMG brands including BioInformatics, SDi, and IMV, expanding its reach across the life sciences and clinical diagnostics landscape..

Kalorama还与其他SMG品牌合作，包括BioInformatics、SDi和IMV，扩大其在生命科学和临床诊断领域的影响。

SOURCE Kalorama Information

来源：Kalorama Information

WANT YOUR COMPANY'S NEWS

想要你公司的新闻吗？

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上？

440k+

44万+

Newsrooms &

新闻编辑室 &

Influencers

影响者

9k+

9k+

Digital Media

数字媒体

Outlets

插座

270k+

27万+

Journalists

记者

Opted In

已选择加入

GET STARTED

开始使用